eMedicine Specialties > Otolaryngology and Facial Plastic Surgery > Skull Base

Skull Base, Tumors, Other CPA Tumors

Author: Jack A Shohet, MD, Associate Clinical Professor, Department of Otolaryngology-Head and Neck Surgery, University of California Irvine; Otolaryngologist, Shohet Ear Associates Medical Group, Inc
Contributor Information and Disclosures

Updated: Feb 12, 2009

Introduction

Cerebellopontine angle (CPA) tumors are the most common neoplasms in the posterior fossa, accounting for 5-10% of intracranial tumors. Most CPA tumors are benign, with over 85% being vestibular schwannomas (acoustic neuromas), lipomas, vascular malformations, and hemangiomas. The most frequent nonacoustic CPA tumors are meningiomas, epidermoids (primary cholesteatomas), and facial or lower cranial nerve schwannomas. Primary malignancies or metastatic lesions account for less than 2% of neoplasms in the CPA.

History of the Procedure

Early in the 20th century, CPA lesions were difficult to diagnose and rarely completely excised. Indeed, the mortality rate for operative intervention in the posterior fossa approached 50%. However, revolutionary advances in neuroradiologic imaging and surgical techniques and approaches have made these lesions almost uniformly treatable with acceptable morbidity and very low rates of mortality. Surgical intervention remains the most definitive means for complete tumor removal for most of these lesions. Radiation therapy has gained popularity to arrest tumor growth with specific tumor types and is also an option for patients who are unwilling or medically unable to undergo surgery.

Problem

The density of vital neurologic structures in the posterior fossa requires careful assessment and treatment planning to avoid unnecessary morbidity and mortality.

Frequency

  • CPA tumors other than vestibular schwannoma (percentage of total CPA occurrence)
    • Meningiomas (3-13%)
    • Epidermoids (2-6%)
    • Facial and lower cranial nerve schwannomas (1-2%)
    • Arachnoid cysts (1%)
  • Rare tumors
    • Lipomas
    • Dermoid tumors
    • Neuroepithelial cysts
    • Trigeminal schwannoma
    • Endolymphatic sac carcinomas
    • Ependymoma
    • Brainstem glioma
    • Astrocytoma
    • Medulloblastoma
    • Choroid plexus papilloma
    • Large or giant aneurysms of anterior inferior cerebellar artery (AICA), superior cerebellar artery (SCA), or the midbasilar artery
    • Brainstem arteriovenous malformation (AVM)
    • Brainstem cavernous malformation originating in the brain stem (may reach a pial surface along the CPA)
    • Petroclival chondrosarcoma
    • Clivus chordoma (usually arise in midline but may extend laterally into the CPA)
    • Osteosarcoma of the lateral skull base
    • Metastatic tumors (can reach CPA by hematogenous spread or direct extension)
    • Granulomatous inflammatory masses

Pathophysiology

  • Meningioma
    • Meningiomas arise from cap cells gathered in clusters around the tips of arachnoid villi.
    • They are benign but locally aggressive.
    • The 4 histologic variants of meningioma are (1) meningothelial (syncytial), (2) fibroblastic, (3) transitional, and (4) angioblastic. Although the angioblastic variant has been associated with more aggressive behavior, no significant correlation has been found between the other histologic subtypes and clinical behavior.
    • In the posterior fossa, they usually arise on the posterior surface of the petrous bone, near the porous acusticus, or along the lateral venous sinus.
    • They displace but do not invade adjacent neural tissue.
    • Meningiomas usually have a thin investing capsule.
    • They can invade bone without destruction by extension along haversian canals.
    • Sixty percent extend into the middle fossa.
    • Psammoma bodies are observed on microscopic examination.
  • Epidermoid
    • Epidermoids originate from epithelial rests within the temporal bone or CPA.
    • They consist of stratified squamous epithelial linings surrounding desquamated keratin.
    • They usually grow very slowly.
    • Patients often do not present until the second to fourth decade of life.
    • Epidermoids tend to envelop rather than displace adjacent neural and vascular structures.
    • Shapes are variable, with irregular patterns.
    • Epidermoids frequently develop multiple fingerlike projections between cranial nerves and brainstem fissures and sulci.
    • They may extend through the tentorium into the middle fossa, forming a dumbbell shape.
  • Facial and lower cranial nerve schwannoma: These arise from Schwann cells anywhere along the course of the nerve.
  • Arachnoid cysts: These are thin-walled sacs containing yellow cerebral spinal fluid (CSF) that most likely originate as congenital developmental anomalies.

Presentation

  • Presenting symptoms of CPA tumors (including acoustic neuromas) include the following:
    • Hearing loss - 95%
    • Tinnitus - 80%
    • Vertigo/unsteadiness - 50-75%
    • Headache - 25%
    • Facial hypesthesia - 35-50%
    • Diplopia - 10%
  • Presenting symptoms can vary according to the size and location of the lesion.

Meningioma

  • Trigeminal or facial nerve symptoms are likely to occur earlier than hearing loss.
  • Patients with larger tumors can present with obstructive hydrocephalus and/or symptoms of brainstem compression.

Epidermoid

  • These can become quite large without symptoms.
  • Facial twitching (hemifacial spasm) and progressive facial paralysis is more prominent than with other tumors in the CPA.
  • Patients may present with cranial nerve or cerebellar dysfunction that develops over a number of years.

Facial nerve schwannoma

  • Clinical findings depend on the portion of the nerve affected by the neoplasm.
  • Patients can present with conductive hearing loss from middle ear involvement, parotid mass from extratemporal involvement, or sensorineural loss from internal auditory canal (IAC) or CPA involvement.
  • CPA lesions do not cause facial weakness until tumor is very large (hemangiomas of the facial nerve usually cause symptoms at an earlier stage).
  • Hemifacial spasm is relatively common.

Lower cranial nerve schwannoma

  • Patients may have weakness and hypesthesia of the palate, vocal cord, and shoulder (cranial nerves [CN] IX, X, XI) or hemiatrophy of the tongue (CN XII).
  • Large tumors may cause deficits of all the lower cranial nerves.

Indications

Because of the location of these tumors within the cerebellopontine angle (CPA) and the significant number of closely associated vital neurologic structures, the risk of complications from cranial nerve damage and brainstem compression increases with delays in diagnosis and treatment. Patient age and medical condition, specific tumor growth rate, and pathologic behavior are taken into account when recommending a mode of therapy. Surgical resection is considered for any patient in good medical condition with a benign or malignant lesion in the CPA if the boundaries of the tumor are resectable with minimal risk to the local neurologic structures. Surgical resection renders the greatest chance for complete tumor eradication of the vast majority of CPA lesions. Occasionally, planned partial resection is considered in patients with extensive tumors associated with increased intracranial pressure.

Relevant Anatomy

See the Pathophysiology section.

Contraindications

Although patient age and medical condition, specific tumor growth rate, and pathologic behavior are taken into account when recommending a mode of therapy, surgical resection is considered for any patient in good medical condition with a benign or malignant lesion in the cerebellopontine angle (CPA) if the boundaries of the tumor are resectable with minimal risk to the local neurologic structures. Occasionally, complete resection is impossible because of the intimate involvement of surrounding structures, which may impose unwarranted morbidity if complete excision is attempted, and planned partial resection is considered.

More on Skull Base, Tumors, Other CPA Tumors

Overview: Skull Base, Tumors, Other CPA Tumors
Workup: Skull Base, Tumors, Other CPA Tumors
Treatment: Skull Base, Tumors, Other CPA Tumors
Follow-up: Skull Base, Tumors, Other CPA Tumors
References

References

  1. Haberkamp TJ, Monsell EM, House WF, Levine SC, Piazza L. Diagnosis and treatment of arachnoid cysts of the posterior fossa. Otolaryngol Head Neck Surg. Oct 1990;103(4):610-4. [Medline].

  2. Langman AW, Jackler RK, Althaus SR. Meningioma of the internal auditory canal. Am J Otol. May 1990;11(3):201-4. [Medline].

  3. Lo WM. Tumors of the temporal bone and cerebellopontine angle. In: Som PM, Bergeron RT, eds. Head and Neck Imaging. St. Louis, Mo: Mosby; 1991.

  4. McElveen JT, Saunders JE. Tumors of the cerebellopontine angle: neuro-otologic aspects of diagnosis. In: Wilkins RH, Rengachary SS, eds. Neurosurgery. New York, NY: McGraw-Hill; 1996:1038-1048.

  5. Nadol JB. Cerebellopontine angle tumors. In: Nadol JB, Schuknecht, HF, eds. Surgery of the Ear and Temporal Bone. New York, NY: Raven Press; 1993:391-413.

Further Reading

Keywords

skull base tumors, skull tumors, CPA tumors, cerebellopontine angle tumors, intracranial tumors, posterior fossa neoplasms, lateral skull base neoplasms, nonacoustic cerebellopontine angle tumors, non-acoustic CPA tumors, vestibular schwannomas, acoustic neuromas, lipomas, vascular malformations, hemangiomas, meningiomas, epidermoids, cholesteatomas, facial schwannomas, lower cranial nerve schwannomas

Contributor Information and Disclosures

Author

Jack A Shohet, MD, Associate Clinical Professor, Department of Otolaryngology-Head and Neck Surgery, University of California Irvine; Otolaryngologist, Shohet Ear Associates Medical Group, Inc
Jack A Shohet, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Medical Association, American Neurotology Society, American Tinnitus Association, and California Medical Association
Disclosure: Envoy Medical Consulting fee Consulting

Medical Editor

Douglas D Backous, MD, Director of Listen for Life Center, Department of Otolaryngology-Head and Neck Surgery, Virginia Mason Medical Center
Douglas D Backous, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Auditory Society, American College of Surgeons, American Laryngological Rhinological and Otological Society, American Medical Association, Association for Research in Otolaryngology, North American Skull Base Society, Society for Neuroscience, and Washington State Medical Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Gerard J Gianoli, MD, Clinical Associate Professor, Department of Otolaryngology-Head and Neck Surgery, Tulane University School of Medicine; Vice President, The Ear and Balance Institute; Chief Executive Officer, Ponchartrain Surgery Center
Gerard J Gianoli, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Neurotology Society, American Otological Society, Society of University Otolaryngologists-Head and Neck Surgeons, and Triological Society
Disclosure: Nothing to disclose.

CME Editor

Christopher L Slack, MD, Otolaryngology-Facial Plastic Surgery, Private Practice, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders
Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine
Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society
Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation unstricted gift unknown

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.